Broadwood Capital Inc 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Broadwood Capital Inc disclosed 7 US equity positions worth $1.3bn in its Q3 2024 13F filing. The largest position was MNST at 33.2% of the reported book, followed by STAA and AXON.
What did Broadwood Capital Inc own in Q3 2024? Top 7 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | MNST MONSTER BEVERAGE CORP NEW | Consumer Defensive | 33.2% | $432.8m | 8,295,690 | – | |
| 2 | STAA STAAR SURGICAL CO | Healthcare | 30.7% | $400.0m | 10,768,431 | – | |
| 3 | AXON AXON ENTERPRISE INC | Industrials | 23.3% | $303.7m | 760,062 | – | |
| 4 | IWM ISHARES TR | 8.8% | $114.8m | 519,920 | – | ||
| 5 | LCTX LINEAGE CELL THERAPEUTICS IN | 2.9% | $37.7m | 41,666,255 | – | ||
| 6 | IMDX ONCOCYTE CORP | 1.1% | $14.0m | 4,929,066 | – | ||
| 7 | SERINA THERAPEUTICS INC | 0.0% | $570.1k | 85,219 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.